Target
Galactokinase
Ligand
BDBM249814
Substrate
n/a
Meas. Tech.
qHTS Assay
IC50
61078.1±n/a nM
Citation
 Boxer, MBWalsh, MJLiu, LTanega, CDShen, MLai, KTang, MAuld, DS Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders US Patent  US9447087 Publication Date 9/20/2016 
Target
Name:
Galactokinase
Synonyms:
GALK | GALK1 | GALK1_HUMAN | Galactokinase | Galactokinase (GALK) | Galactose kinase
Type:
Enzyme
Mol. Mass.:
42271.26
Organism:
Homo sapiens (Human)
Description:
P51570
Residue:
392
Sequence:
MAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGKESLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL
  
Inhibitor
Name:
BDBM249814
Synonyms:
US9447087, 47
Type:
Small organic molecule
Emp. Form.:
C22H20N4O2
Mol. Mass.:
372.4198
SMILES:
Cc1ccc(cc1)C1N=C(Nc2nc3ccccc3o2)NC2=C1C(=O)CCC2 |c:24,t:9|
Structure:
Search PDB for entries with ligand similarity: